Combining Preoperative and Postoperative Inflammatory Indicators Can Better Predict the Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy

References

• Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604. doi:10.1038/s41575-019-0186-y
   PubMed Web of Science ®Google Scholar
• Ng KKC, Chok KSH, Chan ACY, et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma. Br J Surg. 2017;104(13):1775–1784. doi:10.1002/bjs.10677
   PubMed Web of Science ®Google Scholar
• Di Sandro S, Centonze L, Pinotti E, et al. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases. Updates Surg. 2019;71(2):285–293. doi:10.1007/s13304-019-00649-w
   PubMed Web of Science ®Google Scholar
• Duseja A. Staging of hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4(Suppl 3):S74–79. doi:10.1016/j.jceh.2014.03.045
   PubMedGoogle Scholar
• Chen LJ, Chang YJ, Chang YJ. Survival predictability between the american joint committee on cancer 8th edition staging system and the barcelona clinic liver cancer classification in patients with hepatocellular carcinoma. Oncologist. 2021;26(3):e445–e453. doi:10.1002/onco.13535
   PubMed Web of Science ®Google Scholar
• Ringelhan M, Pfister D, O’Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(3):222–232. doi:10.1038/s41590-018-0044-z
   PubMed Web of Science ®Google Scholar
• Yu LX, Ling Y, Wang HY. Role of nonresolving inflammation in hepatocellular carcinoma development and progression. NPJ Precis Oncol. 2018;2(1):6. doi:10.1038/s41698-018-0048-z
   PubMed Web of Science ®Google Scholar
• Dharmapuri S, Ozbek U, Lin JY, et al. Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy. Cancer Med. 2020;9(14):4962–4970. doi:10.1002/cam4.3135
   PubMed Web of Science ®Google Scholar
• Wu SJ, Lin YX, Ye H, Li FY, Xiong XZ, Cheng NS. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy. J Surg Oncol. 2016;114(2):202–210. doi:10.1002/jso.24297
   PubMed Web of Science ®Google Scholar
• Ismael MN, Forde J, Milla E, Khan W, Cabrera R. Utility of inflammatory markers in predicting hepatocellular carcinoma survival after liver transplantation. Biomed Res Int. 2019;2019:7284040.
   PubMed Web of Science ®Google Scholar
• Zheng J, Cai J, Li H, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a meta-analysis and systematic review. Cell Physiol Biochem. 2017;44(3):967–981. doi:10.1159/000485396
   PubMedGoogle Scholar
• Wang Z, Wang J, Wang P. The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: a meta-analysis of observational studies. PLoS One. 2018;13(10):e0202987. doi:10.1371/journal.pone.0202987
   PubMed Web of Science ®Google Scholar
• Song W, Tian C, Wang K, Zhang RJ, Zou SB. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: a meta-analysis. Sci Rep. 2017;7:46601. doi:10.1038/srep46601
   PubMed Web of Science ®Google Scholar
• Rashid OM, Nagahashi M, Ramachandran S, et al. Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. Surgery. 2013;153(6):771–778. doi:10.1016/j.surg.2013.02.002
   PubMed Web of Science ®Google Scholar
• Wu M, Yang S, Feng X, Yu F, Liu X, Dong J. Preoperative plus postoperative neutrophil-lymphocyte ratio for predicting overall survival following partial hepatectomy for hepatocellular carcinoma. Oncol Lett. 2020;20(6):375. doi:10.3892/ol.2020.12238
   PubMed Web of Science ®Google Scholar
• Dan J, Zhang Y, Peng Z, et al. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PLoS One. 2013;8:3. doi:10.1371/journal.pone.0058184
   Web of Science ®Google Scholar
• Peng W, Li C, Wen T-F, et al. Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival. Journal of Surgical Research. 2014;192(2):402–408. doi:10.1016/j.jss.2014.05.078
   PubMed Web of Science ®Google Scholar
• National Hepatobiliary Standard Database of China. Primary Hepatocellular Carcinoma Dataset of Beijing Tsinghua Changgung Hospital 2014-2019; 2021. Available from: http://www.udimed.org/CDR/20210099. Accessed May 1, 2021.
   Google Scholar
• Ji GW, Zhu FP, Xu Q, et al. Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a Multi-Institutional Study. Radiology. 2020;294(3):568–579. doi:10.1148/radiol.2020191470
   PubMed Web of Science ®Google Scholar
• Hurt B, Schulick R, Edil B, El Kasmi KC, Barnett C Jr. Cancer-promoting mechanisms of tumor-associated neutrophils. Am J Surg. 2017;214(5):938–944. doi:10.1016/j.amjsurg.2017.08.003
   PubMed Web of Science ®Google Scholar
• Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol. 2018;11(1):125. doi:10.1186/s13045-018-0669-2
   PubMed Web of Science ®Google Scholar
• Yunger S, El A B, Zeltzer LA, et al. Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy. Oncoimmunology. 2019;8(12):e1672494. doi:10.1080/2162402X.2019.1672494
   PubMed Web of Science ®Google Scholar
• Zhang E, Yang P, Gu J, et al. Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy. J Hematol Oncol. 2018;11(1):102. doi:10.1186/s13045-018-0646-9
   PubMed Web of Science ®Google Scholar
• Jiang Y, Tu X, Zhang X, et al. Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy. Support Care Cancer. 2020;28(11):5569–5579. doi:10.1007/s00520-020-05478-x
   PubMed Web of Science ®Google Scholar
• Jakubowska K, Koda M, Kisielewski W, Kanczuga-Koda L, Grudzinska M, Famulski W. Pre- and postoperative neutrophil and lymphocyte count and neutrophil-to-lymphocyte ratio in patients with colorectal cancer. Molecular and Clinical Oncology. 2020;13(5):56. doi:10.3892/mco.2020.2126
   PubMed Web of Science ®Google Scholar
• Jin F, Han A, Shi F, Kong L, Yu J. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer. Oncotargets and Therapy. 2016;9:6529–6537. doi:10.2147/OTT.S117290
   PubMed Web of Science ®Google Scholar
• Min KW, Kwon MJ, Kim DH, et al. Persistent elevation of postoperative neutrophil-to-lymphocyte ratio: a better predictor of survival in gastric cancer than elevated preoperative neutrophil-to-lymphocyte ratio. Sci Rep. 2017;7(1):13967. doi:10.1038/s41598-017-13969-x
   PubMed Web of Science ®Google Scholar
• He W, Wei M, Yang X, et al. Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer? Medicine. 2017;96(17).
   Web of Science ®Google Scholar
• Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68(3):526–549.
   PubMed Web of Science ®Google Scholar
• Erstad DJ, Tanabe KK. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol. 2019;26(5):1474–1493. doi:10.1245/s10434-019-07227-9
   PubMed Web of Science ®Google Scholar
• de Oliveira S, Rosowski EE, Huttenlocher A. Neutrophil migration in infection and wound repair: going forward in reverse. Nat Rev Immunol. 2016;16(6):378–391. doi:10.1038/nri.2016.49
   PubMed Web of Science ®Google Scholar
• Pravisani R, Mocchegiani F, Isola M, et al. Postoperative trends and prognostic values of inflammatory and nutritional biomarkers after liver transplantation for hepatocellular carcinoma. Cancers (Basel. 2021;13(3):513. doi:10.3390/cancers13030513
   PubMed Web of Science ®Google Scholar
• Hayama T, Hashiguchi Y, Okada Y, et al. Significance of the 7th postoperative day neutrophil-to-lymphocyte ratio in colorectal cancer. Int J Colorectal Dis. 2020;35(1):119–124. doi:10.1007/s00384-019-03463-3
   PubMed Web of Science ®Google Scholar